Table 5:
VA-ECMO implantation-related aspects, duration of VA-ECMO and complications among survivors and non-survivors
| Variables | Survivors (n = 73) | Non-survivors (n = 100) | P-value |
|---|---|---|---|
| Antegrade cannulation | 39 (53.4) | 63 (63.0) | 0.206 |
| Retrograde cannulation | 34 (46.6) | 37 (37.0) | 0.206 |
| Time until VA-ECMO implantationa (min) | 240 (30–507) | 283 (41–840) | 0.509 |
| Days on VA-ECMO (days) | 5 (3–7) | 5 (2–8) | 0.282 |
| ECMO-related complications | 49 (67.1) | 86 (86.0) | 0.003 |
| Bleeding | 36 (49.3) | 71 (71.0) | 0.004 |
| Re-exploration for bleeding | 24 (32.9) | 31 (31.0) | 0.793 |
| Acute renal failure | 28 (38.4) | 53 (53.0) | 0.057 |
| Acute liver failure | 1 (1.4) | 12 (12.0) | 0.009 |
| Sepsis | 7 (9.6) | 5 (5.0) | 0.241 |
Values are represented as number (percentage) or median (interquartile range). P values < 0.05 in bold are statistically significant.
a
Time elapsed from cardiopulmonary bypass stop to VA-ECMO implantation.
VA-ECMO: venoarterial extracorporeal membrane oxygenation.